COMMUNIQUÉS West-GlobeNewswire

-
New study to investigate impact of proactive-voice caregiving for heart failure patients announced
27/08/2019 -
North Springs Psychiatry Hosts Open House to Debut Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)
27/08/2019 -
AmblyoPlay Now Offers its Vision Therapy Solution for Lazy Eye in the U.S.
27/08/2019 -
Oasmia updates regarding MGC disputes
27/08/2019 -
Alphatec Announces Favorable Judgment in NuVasive v. Miles Lawsuit
27/08/2019 -
Synchronicity Pharma Highlights New Research Demonstrating Beneficial Effects of Modulating Core Clock Proteins in Glioblastoma Stem Cells
27/08/2019 -
CV Sciences, Inc Appoints Terri Funk Graham to Board of Directors
27/08/2019 -
Ceapro Announces Research Funding Award from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada for Joint Projects with McMaster University
27/08/2019 -
Trading in Coloplast shares by board members, executives or associated persons
27/08/2019 -
Acer Therapeutics to Present at the 21st Annual H.C. Wainwright Global Investment Conference
27/08/2019 -
Fluidigm and the Icahn School of Medicine at Mount Sinai Collaborate on Landmark Single-Cell Study of the Human Epigenome
27/08/2019 -
Myovant Sciences to Participate in Upcoming September Investor Conferences
27/08/2019 -
Principia to Present at the 2019 Baird Global Healthcare Conference and the Wells Fargo Healthcare Conference
27/08/2019 -
Chris Cournoyer Joins CareDx Board of Directors
27/08/2019 -
AMAG Pharmaceuticals Announces Commercial Availability of Vyleesi™ (Bremelanotide Injection)
27/08/2019 -
Integrated Cannabis Enters into Exclusive Distribution Partnership with Nabis, One of California’s Largest Type 11 Cannabis Distributors
27/08/2019 -
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
27/08/2019 -
Mustang Bio Announces License Agreement with CSL Behring for the Cytegrity™ Stable Producer Cell Line for the Production of MB-107 Lentiviral Gene Therapy
27/08/2019 -
Outlook Therapeutics to Present at the H.C. Wainwright 21st Annual Healthcare Conference
27/08/2019
Pages